Qualis Innovations, Inc. (QLIS)
Qualis Innovations, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Chadds Ford, PA, US. The stock last traded at $0.27, up 0.00% on the session, giving a market capitalisation of $5.5M. On trailing twelve-month figures it carries a trailing P/E of -49.39, a net margin of -11.1%. Its beta of -2.76 implies it has historically moved less than the broad market.
Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and distribution of solutions primarily targeting pain management and other disorders affecting the central nervous system (CNS). The company's flagship product is SOLACE, an advanced, non-invasive medical device. SOLACE functions by employing electromagnetic induction to produce therapeutic deep heat beneath the skin's surface, thereby alleviating and reducing pain. Qualis Innovations, Inc. maintains its corporate headquarters in Chadds Ford, Pennsylvania.
Qualis Innovations, Inc. is most often compared with the following Healthcare names: